KALOBIOS PHARMACEUTICALS INC
KALOBIOS PHARMACEUTICALS INC (KBIO) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 97 transactions totaling $18.3M, demonstrating a bullish sentiment with $4.5M in net insider flow. The most recent transaction on Aug 26, 2016 involved a sale of 309,723 shares valued at $960.1K.
KBIO Insider Activity Summary
Who Is Buying KBIO Stock?
No significant insider buying has been recorded for KBIO in the recent period.
Who Is Selling KBIO Stock?
No significant insider selling has been recorded for KBIO in the recent period.
Is KALOBIOS PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KBIO is bullish with an Insider Alignment Score of 62/100 and a net flow of $4.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KBIO Frequently Asked Questions
Understanding KBIO Insider Activity
Insider trading at KALOBIOS PHARMACEUTICALS INC (KBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading KBIO stock, having executed 97 transactions in the past 90 days. The most active insider is Martin Shkreli (Executive), who has made 9 transactions totaling $9.7M.
Related Tools
Track KALOBIOS PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at KBIO file new Form 4 transactions